Quinidine

potassium sodium-activated channel subfamily T member 1 ; Homo sapiens







27 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35369761 Small-molecule inhibitors of Slack potassium channels as potential therapeutics for childhood epilepsies. 2022 Apr 4 2
2 34122071 Case Report of Novel Genetic Variant in KCNT1 Channel and Pharmacological Treatment With Quinidine. Precision Medicine in Refractory Epilepsy. 2021 2
3 32505479 KCNT1-positive epilepsy of infancy with migrating focal seizures successfully treated with nonnarcotic antitussive drugs after treatment failure with quinidine: A case report. 2020 Sep 2
4 30782581 Quinidine therapy and therapeutic drug monitoring in four patients with KCNT1 mutations. 2019 Feb 1 4
5 30804880 Quinidine Therapy for Lennox-Gastaut Syndrome With KCNT1 Mutation. A Case Report and Literature Review. 2019 3
6 31054119 Treatment Responsiveness in KCNT1-Related Epilepsy. 2019 Jul 1
7 31072785 Corrigendum to "Does age affect response to quinidine in patients with KCNT1 mutations? Report of three new cases and review of the literature" [Seizure 55 (February) (2018) 1-3]. 2019 Jul 1
8 31208268 Two Patients With KCNT1-Related Epilepsy Responding to Phenobarbital and Potassium Bromide. 2019 Oct 1
9 31359944 Two South Indian Children with KCNT1-Related Malignant Migrating Focal Seizures of Infancy - Clinical Characteristics and Outcome of Targeted Treatment with Quinidine. 2019 Jul-Sep 2
10 31388363 Concurrent Quinidine and Phenobarbital in the Treatment of a Patient with 2 KCNT1 Mutations. 2019 2
11 29037447 A quinidine non responsive novel KCNT1 mutation in an Indian infant with epilepsy of infancy with migrating focal seizures. 2018 Mar 2
12 29196578 Precision therapy for epilepsy due to KCNT1 mutations: A randomized trial of oral quinidine. 2018 Jan 2 2
13 29196579 Clinical and molecular characterization of KCNT1-related severe early-onset epilepsy. 2018 Jan 2 1
14 29291456 Does age affect response to quinidine in patients with KCNT1 mutations? Report of three new cases and review of the literature. 2018 Feb 3
15 29866938 Reader response: Quinidine-associated skin discoloration in KCNT1-associated pediatric epilepsy. 2018 Jun 5 1
16 29866939 Author response: Quinidine-associated skin discoloration in KCNT1-associated pediatric epilepsy. 2018 Jun 5 1
17 29866940 Quinidine-associated skin discoloration in KCNT1-associated pediatric epilepsy. 2018 Jun 5 1
18 30112700 Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy. 2018 Oct 5
19 30182418 Lack of response to quinidine in KCNT1-related neonatal epilepsy. 2018 Oct 2
20 27578169 Quinidine therapy for West syndrome with KCNTI mutation: A case report. 2017 Jan 3
21 29158296 Quinidine-associated skin discoloration in KCNT1-associated pediatric epilepsy. 2017 Nov 21 1
22 26748457 Ineffective quinidine therapy in early onset epileptic encephalopathy with KCNT1 mutation. 2016 Mar 1
23 26784557 Characterization of two de novoKCNT1 mutations in children with malignant migrating partial seizures in infancy. 2016 Apr 2
24 26022171 Genetics of pediatric epilepsy. 2015 Jun 1
25 26369628 Quinidine in the treatment of KCNT1-positive epilepsies. 2015 Dec 2
26 25042079 Targeted treatment of migrating partial seizures of infancy with quinidine. 2014 Sep 2
27 16876206 Pharmacological activation and inhibition of Slack (Slo2.2) channels. 2006 Sep 1